One-Week Use of Oxymetazoline Nasal Spray in Patients with Rhinitis medicamentosa 1 Year after Treatment

ORL

Volumn 59, Issue 1, 1997, Pages 39-44

  Graf, Peter ^a   Hallén, Hans ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Benzalkonium chloride; Histamine challenge; Oxymetazoline; Rhinitis medicamentosa; Rhinostereometry; Vasoconstrictors

Indexed keywords

BENZALKONIUM CHLORIDE; HISTAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NOSE CAVITY; NOSE MUCOSA; NOSE OBSTRUCTION; PRIORITY JOURNAL; PROVOCATION TEST; RHINITIS; SURFACE PROPERTY;

EID: 0030894282     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000276903     Document Type: Article

References (22)

1. Lake C: Rhinitis medicamcntosa, Mayo Clin Proc 1946;21:367-371.
2. Graf P: Overuse of Oxy- and Xylomctazoline Nasal Sprays: Changes in Nasal Mucosal Swelling and Histamine Sensitivity in Healthy Subjects and in Patients with Rhinitis medicamentosa: thesis Karolinska Institute, 1994.
3. Baldwin R: Rhinitis medicamentosa (an approach to treatment), J Med Assoc State Ala 1977:47:33-35.
4. Toohill R, Lehman R, Grossman T, Belson T: Rhinitis medicamentosa, Laryngoscope 1981: 91:1614-1621.
5. Walker J: Rhinitis medicamentosa, J Allergy 1952;23:183-186.
6. Feinberg A, Feinberg S: The ‘nose drop nose’ due to oxymetazoline (Afrin) and other topical vasoconstrictors, Ill Med J 1971;140:50-52.
7. Fleece L, Mizes J, Jolly P, Baldwin R: Rhinitis medicamentosa, Ala J Med Sci 1984:21:205-208.
8. Graf P, Hallen H, J uto J-E: The pathophysiology and treatment of rhinitis medicamentosa, Clin Otolaryngol 1995;20:224-229.
9. Rijntjes E: Nose-Drop Abuse, a Functional and Morphological Study; thesis University of Leiden, 1985.
10. Juto JE, Lundberg C: An optical method for determining changes in mucosal congestion in the nose in man, Acta Otolaryngol (Stockh) 1982;94:149-156.
11. Graf P, Juto J-E: Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline, ORL 1994;56:131-134.
12. Hallen H, Juto J-E: Nasal mucosa reaction: A model for mucosal reaction during challenge, Rhinology 1992;30:129-133.
13. Hallen H, Juto J-E: A test for objective diagnosis of nasal hyperreactivity, Rhinology 1993; 31:23-25.
14. Hallen H, Graf P: Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers, Clin Exp Allergy 1995:25:401-405.
15. Batts A, Marriot C, Martin G, Bond S: The effect of some preservatives used in nasal preparations on mucociliary clearance, J Pharm Pharmacol 1989;41:156-159.
16. Van de Donk H, Muller-Plantema I, Zuidema J, Merkus F: The effects of preservatives on the ciliary beat frequency of the chicken embryo tracheas, Rhinology 1980:18:119-133.
17. Van de Donk H, Zuidema J, Merkus F: The effects of nasal drops on the ciliary beat frequency of chicken embryo tracheas, Rhinology 1981;19:215-230.
18. Hakansson B, Linder C, Ohlsson K, Tegner H, Torsmalm N: The inhibition of granulocyte phagocytosis by various components of nasal drops, Pharmacol Toxicol 1989;65:89-91.
19. Hakansson B, Forsgren A, Tegner H, Torc-malm N: Inhibitory effects of nasal drop components on granulocyte chcmotaxis, Pharmacol Toxicol 1989;64:321-323.
20. Bjerknes R, Steinsvag K: Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decon-gestive nosedrops, Pharmacol Toxicol 1993:73: 41-45.
21. Graf P, Hallen H, Juto J-E: Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers, Clin Exp Allergy 1995;25:395-400.
22. Akerlund A, Bende M: Sustained use of xylo-metazoline nose drops aggravates vasomotor rhinitis, Am J Rhinol 1991.5:157-160.